FREDERICTON — New Brunswick has become the latest province to offer a third dose of the Pfizer-BioNTech COVID-19 vaccine to certain groups of immunocompromised residents.
Chief medical officer Dr. Jennifer Russell said in a news release today that those who are immunocompromised could have a reduced immune system response to the vaccine, so an additional dose could provide better protection.
Those eligible for a third dose include people with cancer receiving chemotherapy, organ transplant recipients receiving immunosuppressive therapy, people living with untreated or advanced HIV infection or AIDS and people born with moderate to severe immune system dysfunction.
Officials say a third dose should be administered at least four weeks after a second dose.
The announcement comes as 52 new COVID-19 cases were reported in the province, bringing its active case count to 574, with 27 people in hospital, including 12 in intensive care.
Officials say cases have been recorded in several schools and child care facilities in the Moncton and Edmundston regions, as well.
Three-quarters of the new cases reported involved people who were not fully vaccinated. Public health officials say 78.4 per cent of eligible New Brunswickers are fully vaccinated against COVID-19 while 87.1 per cent have received at least one dose.
This report by The Canadian Press was first published Sept. 23, 2021.
— — —
This story was produced with the financial assistance of the Facebook and Canadian Press News Fellowship.
The Canadian Press